bioAffinity Technologies
BIAF
10 hedge funds and large institutions have $231K invested in bioAffinity Technologies in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
65% more capital invested
Capital invested by funds: $140K → $231K (+$90.8K)
11% more funds holding
Funds holding: 9 → 10 (+1)
0.01% more ownership
Funds ownership: 0.04% → 0.05% (+0.01%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$52.5K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
+$7.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$5.35K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.54K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$76 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $58.7K | -$5.35K | -125 | -9% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $54.8K | +$52.5K | +1,226 | New |
|
3
Two Sigma Investments
New York
| $31.8K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $29.4K | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $26.2K | – | – | – |
|
6
Creative Planning
Overland Park,
Kansas
| $17.8K | – | – | – |
|
|
IA
7
IFP Advisors
Tampa,
Florida
| $7.35K | +$7.14K | +167 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4.36K | -$1.54K | -36 | -27% |
|
9
Wells Fargo
San Francisco,
California
| $60 | – | – | – |
|
10
Qube Research & Technologies (QRT)
London,
United Kingdom
| $57 | – | – | – |
|
11
JP Morgan Chase
New York
| $13 | – | – | – |
|
12
Bank of America
Charlotte,
North Carolina
| $8 | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$76 | -2 | Closed |
|
BIAF Hedge Fund Activity: Q4 2023 in Review
10 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q4 2023, worth a combined $231K — up 65% from $140K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIAF positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $52.5K. The largest seller was CAPTRUST Financial Advisors, cutting an estimated $5.35K.
- 10 institutional investors held bioAffinity Technologies (BIAF) as of Q4 2023, up from 9 in Q3 2023.
- Funds reported $231K of bioAffinity Technologies stock for Q4 2023, up 65% quarter-over-quarter.
- 2 funds opened new bioAffinity Technologies positions in Q4 2023 and 1 closed out, a net change of +1 holder.
- The largest bioAffinity Technologies buyer in Q4 2023 was Geode Capital Management, an estimated $52.5K added.
- The largest bioAffinity Technologies seller in Q4 2023 was CAPTRUST Financial Advisors, an estimated $5.35K sold.
Based on aggregated 13F filings for Q4 2023.